Mostrar registro simples

dc.contributor.authorFelix, Temis Mariapt_BR
dc.contributor.authorOliveira, Bibiana Mello dept_BR
dc.contributor.authorArtifon, Milenapt_BR
dc.contributor.authorCarvalho, Isabellept_BR
dc.contributor.authorBernardi, Filipe Andradept_BR
dc.contributor.authorSchwartz, Ida Vanessa Doederleinpt_BR
dc.contributor.authorSaute, Jonas Alex Moralespt_BR
dc.contributor.authorFerraz, Victor Evangelista de Fariapt_BR
dc.contributor.authorAcosta, Angelina Xavierpt_BR
dc.contributor.authorSorte, Ney Boapt_BR
dc.contributor.authorAlves, Domingos Savio do Nascimentopt_BR
dc.contributor.authorFaccini, Lavinia Schulerpt_BR
dc.contributor.authorGiugliani, Robertopt_BR
dc.contributor.authorSanseverino, Maria Teresa Vieirapt_BR
dc.contributor.authorRARAS Network Grouppt_BR
dc.date.accessioned2022-10-27T04:49:42Zpt_BR
dc.date.issued2022pt_BR
dc.identifier.issn1750-1172pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/250390pt_BR
dc.description.abstractThe Brazilian Policy of Comprehensive Care for People with Rare Diseases (BPCCPRD) was established by the Ministry of Health to reduce morbidity and mortality and improve the quality of life of people with rare diseases (RD). Several laboratory tests, most using molecular genetic technologies, have been incorporated by the Brazilian Public Health System, and 18 specialised centres have so far been established at university hospitals (UH) in the capitals of the Southern, Southeastern and Northeastern regions. However, whether the available human and technological resources in these services are appropriate and sufficient to achieve the goals of care established by the BPCCPRD is unknown. Despite great advances in diagnosis, especially due to new technologies and the recent structuring of clinical assessment of RD in Brazil, epidemiological data are lacking and when available, restricted to specific disorders. This position paper summarises the performance of a nationally representative survey on epidemiology, clinical status, and diagnostic and therapeutic resources employed for individuals with genetic and non-genetic RD in Brazil. The Brazilian Rare Disease Network (BRDN) is under development, comprising 40 institutions, including 18 UH, 17 Rare Diseases Reference Services and five Newborn Screening Reference Services. A retrospective study will be initially conducted, followed by a prospective study. The data collection instrument will use a standard protocol with sociodemographic data and clinical and diagnostic aspects according to international ontology. This great collaborative network is the first initiative of a large epidemiological data collection of RD in Latin America, and the results will increase the knowledge of RD in Brazil and help health managers to improve national public policy on RD in Brazil.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofOrphanet journal of rare diseases. [London]. Vol. 17 (2022), 84, 13 p.pt_BR
dc.rightsOpen Accessen
dc.subjectAtenção à saúdept_BR
dc.subjectEpidemiologyen
dc.subjectSaúde públicapt_BR
dc.subjectHealthcare systemen
dc.subjectPublic healthen
dc.subjectDoenças raraspt_BR
dc.subjectRare diseasesen
dc.titleEpidemiology of rare diseases in Brazil : protocol of the Brazilian Rare Diseases Network (RARAS-BRDN)pt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001151700pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples